// you're reading...

News

Collaboration with MelliTech, Grenoble, France, on the specificity of monoclonal IC2

License & research collaboration with MelliTech, Grenoble, France, concerning the monoclonal autoantibody IC2 and the ZnT8-transporter in pancreatic beta-cells.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart